APA (7th ed.) Citation

AM, D., A, D., N, S., T, L., AB, W., & NK, K. (2025). Development, Characterization, and in vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer. AAPS PharmSciTech, 26(7), 204. https://doi.org/10.1208/s12249-025-03200-w

Chicago Style (17th ed.) Citation

AM, Diorio, Daram A, Sriram N, Lund T, Watts AB, and Kunda NK. "Development, Characterization, and in Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer." AAPS PharmSciTech 26, no. 7 (2025): 204. https://doi.org/10.1208/s12249-025-03200-w.

MLA (9th ed.) Citation

AM, Diorio, et al. "Development, Characterization, and in Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer." AAPS PharmSciTech, vol. 26, no. 7, 2025, p. 204, https://doi.org/10.1208/s12249-025-03200-w.